Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ITERUM THERAPEUTICS US LTD

  • FDA Approval
  • Oct. 25, 2024, 14:55 UTC
  • 53
  • 0 comments

FDA approve SULOPENEM ETZADROXIL;PROBENECID

Comment Full text

PFIZER

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 49
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

REGENERON PHARMACEUTICALS

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 50
  • 0 comments

FDA approve ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB

Comment Full text

ASPEN GLOBAL INC

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 45
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 48
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 46
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 48
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 44
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

DR REDDYS

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 42
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 47
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text
  • Previous
  • 327
  • 328
  • 329
  • 330
  • 331
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216327)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137438)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin